# Shu Wakino

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/shu-wakino/

## Facts

| Field | Value |
| --- | --- |
| Citations | 8,309 |
| Field | Dialysis and Renal Disease Management |
| h-index | 47 |
| i10-index | 115 |
| Last Known Institution | Tokushima University Hospital |
| OpenAlex ID | https://openalex.org/A5089373241 |
| ORCID iD | 0000-0003-1677-8397 |
| Works | 265 |

## Researcher papers

- [Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes](https://scholariq.org/papers/renal-tubular-sirt1-attenuates-diabetic-albuminuria-by-epigenetically/)
- [Diagnostic Criteria, Clinical Features, and Incidence of Thyroid Storm Based on Nationwide Surveys](https://scholariq.org/papers/diagnostic-criteria-clinical-features-and-incidence-of-thyroid-storm-based-on/)
- [Troglitazone Inhibits Formation of Early Atherosclerotic Lesions in Diabetic and Nondiabetic Low Density Lipoprotein Receptor–Deficient Mice](https://scholariq.org/papers/troglitazone-inhibits-formation-of-early-atherosclerotic-lesions-in-diabetic-and/)
- [Parathyroid hormone activation of the 25-hydroxyvitamin D <sub>3</sub> -1α-hydroxylase gene promoter](https://scholariq.org/papers/parathyroid-hormone-activation-of-the-25-hydroxyvitamin-d-sub-3-sub-1/)
- [2016 Guidelines for the management of thyroid storm from The Japan Thyroid Association and Japan Endocrine Society (First edition)](https://scholariq.org/papers/2016-guidelines-for-the-management-of-thyroid-storm-from-the-japan-thyroid/)
- [Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression](https://scholariq.org/papers/sirt1-protects-against-oxidative-stress-induced-renal-tubular-cell-apoptosis-by/)
- [Kidney-specific Overexpression of Sirt1 Protects against Acute Kidney Injury by Retaining Peroxisome Function](https://scholariq.org/papers/kidney-specific-overexpression-of-sirt1-protects-against-acute-kidney-injury-by/)
- [Ca<sup>2+</sup>Channel Subtypes and Pharmacology in the Kidney](https://scholariq.org/papers/ca-sup-2-sup-channel-subtypes-and-pharmacology-in-the-kidney/)
- [Peroxisome Proliferator-activated Receptor γ Ligands Inhibit Retinoblastoma Phosphorylation and G1 → S Transition in Vascular Smooth Muscle Cells](https://scholariq.org/papers/peroxisome-proliferator-activated-receptor-ligands-inhibit-retinoblastoma/)
- [Cloning and expression of rat 25-hydroxyvitamin D <sub>3</sub> -1α-hydroxylase cDNA](https://scholariq.org/papers/cloning-and-expression-of-rat-25-hydroxyvitamin-d-sub-3-sub-1-hydroxylase-cdna/)
- [The effect of aldosterone and aldosterone blockade on the progression of chronic kidney disease: a randomized placebo-controlled clinical trial](https://scholariq.org/papers/the-effect-of-aldosterone-and-aldosterone-blockade-on-the-progression-of-chronic/)

## Researcher topics

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Diet and metabolism studies](https://scholariq.org/topics/diet-and-metabolism-studies/)
- [Peroxisome Proliferator-Activated Receptors](https://scholariq.org/topics/peroxisome-proliferator-activated-receptors/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)

## Researcher university

- [Tokushima University Hospital](https://scholariq.org/institutions/tokushima-university-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.